CMA Orders Aramark to Divest Entier Due to Competition Concerns
The Competition and Markets Authority's merger investigation concluded in January 2026, mandating Aramark Limited to sell Entier Limited after identifying a substantial reduction in competition in the UK market.
Key Takeaways
- The UK's Competition and Markets Authority ordered Aramark to sell Entier Limited following a merger investigation.
- The main reason was a substantial reduction in competition in key UK markets.
- A special group and a trustee were appointed to oversee the divestment and its compliance.
- The process included public consultations, legal extensions, and detailed publication of reports and final orders.
The Competition and Markets Authority (CMA) of the United Kingdom determined in January 2026 that Aramark Limited must sell Entier Limited due to substantial risks to competition arising from its acquisition. This ruling concluded after a thorough investigation lasting almost a year, with the final order published and a remedies review group appointed in May 2026. The process illustrates the level of scrutiny applied to mergers in the services sector in the UK, particularly in markets such as North Sea catering.
Investigation of the Aramark Limited - Entier Limited Merger
The merger between Aramark Limited and Entier Limited was referred for in-depth investigation on August 5, 2025. According to the CMA, available data suggested that the transaction could lead to a substantial reduction in competition in one or more UK markets for goods or services. The CMA initiated this review under the provisions of the Enterprise Act 2002, after issuing an initial enforcement notice to Aramark on March 25, 2025.
During phase 1, on July 22, 2025, the CMA flagged potential competition issues and warned that, in the absence of adequate commitments, the operation would be investigated in further detail during phase 2.
"The CMA has decided, with the available information, that this merger could lead to a substantial reduction in competition in the UK," the authority stated in its initial decision.
Case Process and Timeline
The case progressed with the following key milestones:
- May 23, 2025: Official opening of the merger investigation and invitation for third-party comments.
- August 5, 2025: The case is referred to phase 2 for advanced scrutiny, chaired by Richard Feasey.
- October 24, 2025: Provisional report identifies signs of competitive issues and parties are invited to respond.
- November 11, 2025: Public consultation on possible remedies opens; deadline for comments is November 18.
- January 15, 2026: Publication of the final report and official announcement requiring Aramark to sell Entier Limited.
- March 18, 2026: The legal investigation period is extended by six weeks, pushing the deadline to May 20, 2026.
- April 30, 2026: Notification and publication of the final divestment order.
- May 1, 2026: The remedies group is appointed to supervise the execution of the final decision, led by Crispin Wright.
Several derogations and extensions were documented, reflecting the complexity and volume of information processed in merger investigations affecting significant operators in the UK services market.
Findings and Competitive Remedies Imposed
The CMA concluded in its final report that the acquisition posed significant risks to competition. In response, the British authority adopted a final order on April 30, 2026, formalizing the mandatory steps to restore competition in the sector.
The primary measures included:
- Mandatory sale of Entier Limited by Aramark Limited, under the supervision of an independent trustee.
- Ongoing oversight during the divestment process, through the appointment and monitoring of a trustee starting December 4, 2025.
- Public consultation on potential remedies and transparency in orders and key documents.
The CMA determined that these measures were necessary due to insufficient voluntary commitments during the initial phases of the case.
Process Oversight Design and Key Appointments
Compliance monitoring was delegated to a remedies group starting in May 2026, consisting of Crispin Wright (Chair), Frances McLeman, and Stephen Rose. An independent trustee was also designated to monitor execution and uphold the standards required by the CMA, formalizing their duties through specific orders issued in mid-2025 and 2026.
The authority managed successive derogations to accommodate critical stages of the divestment process, ensuring rigorous control over the timelines and conditions of the imposed remedy.
Relevance for Operators and Regulatory Oversight in the UK
The CMA's decision in the Aramark/Entier case represents a significant precedent for operators in the services sector and particularly for catering or supply companies in the offshore industry. The authority’s close monitoring and the imposition of a total divestment underscore the strict enforcement of competition policy in significant-scale mergers in the UK market.
Aspects such as consultations with third parties, formal invitations to provide observations, and various extensions in the timeline emphasize the importance of rigorous compliance and transparency in concentration processes in regulated sectors.
To keep up with similar regulatory updates, you can check the coverage of merger reviews, news, and changes in regulatory policies.
Frequently Asked Questions
Why did the CMA order Aramark to sell Entier?
The CMA required Aramark to divest Entier Limited because it identified significant risks of substantial reduction in competition in the UK market after analyzing the acquisition.
What was the key development in the merger investigation between Aramark and Entier?
The central milestone was the publication of the final report on January 15, 2026, and the final divestment order issued on April 30, 2026, concluding almost a year-long investigation.
What measures did the CMA impose to ensure competition in the Aramark/Entier case?
The CMA mandated the compulsory sale of Entier Limited, the designation of a monitoring trustee, and the formation of a remedies review group, ensuring supervised execution.
Who supervised the implementation of the divestment?
A remedies group ('remedy group') chaired by Crispin Wright, accompanied by Frances McLeman and Stephen Rose, along with an independent trustee, oversaw the process from May 2026.
Tags
About the author
Gonzalo Marín
Industry Deals Correspondent
Gonzalo Marín covers the corporate deal flow of gambling — operator strategy, M&A, regulated-market entries, and product launches. The reports open with the transaction, cite companies, valuations, and jurisdictions exactly as released, and keep the announcement apart from its actual effect. When a Latin American operator raises capital or a European brand lands in the region, Gonzalo Marín reports who signs, for how much, and on what terms.
More from Gonzalo Marín
